Literature DB >> 29025376

Roles of microRNA let-7b in papillary thyroid carcinoma by regulating HMGA2.

Hongguang Li1, Lihong Zhao2, Zhenhua Zhang1, Heng Zhang1, Chao Ding1, Zijie Su1.   

Abstract

The incidence of thyroid cancer has increased significantly in the last decade, and the most frequent type of this cancer is papillary thyroid carcinoma. MicroRNAs have been demonstrated to be abnormally expressed in tumors and associated with the development of the tumors. Our aim was to analyze the role and molecular mechanisms of tumor suppressor let-7b in the papillary thyroid carcinoma. Expression of let-7b and high-mobility group A2 in papillary thyroid carcinoma tissues and cell lines was assessed using quantitative reverse transcription polymerase chain reaction and western blot analysis. To explore the role of let-7b or high-mobility group A2 in the BCPAP and TPC-1 cells, 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide and Transwell methods were used. Let-7b expression was significantly downregulated while expression of high-mobility group A2 was upregulated dramatically in papillary thyroid carcinoma tissues and cells compared with that in normal thyroid tissues and cells. In addition, overexpression of let-7b or knockdown of high-mobility group A2 inhibited cell migration and invasion compared with that of control. Besides, high-mobility group A2 was negatively regulated by let-7b in BCPAP cells. Moreover, high-mobility group A2 reintroduction reversed the anti-proliferation, anti-migration, and anti-invasion roles of let-7b. Let-7b might function as a tumor suppressor in papillary thyroid carcinoma by suppressing the expression of high-mobility group A2, and therefore might provide a promising therapeutic target for patients with papillary thyroid carcinoma.

Entities:  

Keywords:  Papillary thyroid carcinoma; high-mobility group A2; let-7b; microRNAs

Mesh:

Substances:

Year:  2017        PMID: 29025376     DOI: 10.1177/1010428317719274

Source DB:  PubMed          Journal:  Tumour Biol        ISSN: 1010-4283


  8 in total

1.  Serine protease HtrA2/Omi regulates adaptive mitochondrial reprogramming in the brain cortex after ischemia/reperfusion injury via UCP2-SIRT3-PGC1 axis.

Authors:  Hao Meng; Lian-Kun Sun; Jing Su; Wan-Yu Yan; Yao Jin; Xin Luo; Xian-Rui Jiang; Hong-Lei Wang
Journal:  Hum Cell       Date:  2021-11-22       Impact factor: 4.174

Review 2.  MicroRNAs as the critical regulators of cell migration and invasion in thyroid cancer.

Authors:  Amir Abbas Hamidi; Negin Taghehchian; Zahra Basirat; Amir Sadra Zangouei; Meysam Moghbeli
Journal:  Biomark Res       Date:  2022-06-04

3.  Decreased let-7b is associated with poor prognosis in glioma.

Authors:  Wanzeng Zhang; Wangmiao Zhao; Chunyan Ge; Xiaowei Li; Xuehui Yang; Yi Xiang; Zhaosheng Sun
Journal:  Medicine (Baltimore)       Date:  2019-05       Impact factor: 1.817

4.  Roles of the SNHG7/microRNA‑9‑5p/DPP4 ceRNA network in the growth and 131I resistance of thyroid carcinoma cells through PI3K/Akt activation.

Authors:  Wanzhi Chen; Jichun Yu; Rong Xie; Tao Zhou; Chengfeng Xiong; Shuyong Zhang; Meijun Zhong
Journal:  Oncol Rep       Date:  2021-03-02       Impact factor: 3.906

5.  lncRNA HOTAIRM1 regulates cell proliferation and the metastasis of thyroid cancer by targeting Wnt10b.

Authors:  Chenyao Li; Xinxin Chen; Tao Liu; Guang Chen
Journal:  Oncol Rep       Date:  2020-12-31       Impact factor: 3.906

6.  E-cadherin Interacts With Posttranslationally-Modified AGO2 to Enhance miRISC Activity.

Authors:  Jie-Ning Li; Hui-Lung Sun; Ming-Yang Wang; Pai-Sheng Chen
Journal:  Front Cell Dev Biol       Date:  2021-07-05

Review 7.  The role of microRNAs in the pathogenesis, grading and treatment of hepatic fibrosis in schistosomiasis.

Authors:  Qianglin Chen; Jianqiang Zhang; Ting Zheng; Hui Chen; Hao Nie; Bing Zheng; Quan Gong
Journal:  Parasit Vectors       Date:  2019-12-30       Impact factor: 3.876

8.  miR-98-5p promotes apoptosis and inhibits migration and cell growth in papillary thyroid carcinoma through Bax/Caspase-3 by HMGA2.

Authors:  Kai Qiu; QingJi Xie; Shan Jiang; Ting Lin
Journal:  J Clin Lab Anal       Date:  2019-10-31       Impact factor: 2.352

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.